KQ Labs

KQ Labs operates as a specialized five-month accelerator program, housed within The Francis Crick Institute, supporting early-stage data-driven health companies. The program specifically targets startups that leverage artificial intelligence for applications in drug discovery and development, precision medicine and diagnostics, and various digital health products. It provides a structured curriculum, strategic introductions to key industry and pharmaceutical leaders, and access to an investor network, establishing a foundational support system for these ventures.

The accelerator launched its initial cohort in 2018, originating as an initiative by The Francis Crick Institute to foster innovation at the critical intersection of biomedical research and data science. This development arose from the recognized need to bridge academic breakthroughs with commercial application, facilitating the translation of advanced scientific knowledge into practical healthcare solutions.

The program primarily serves founders and emerging companies dedicated to developing data-driven healthcare innovations. KQ Labs aims to invest in individuals and cultivate vital connections, thereby accelerating progress in this rapidly evolving sector. Its overarching vision is to transform healthcare by nurturing a vibrant community of startups utilizing data-driven solutions, guiding them toward long-term success.